Sleep without limitations.

If you suffer from obstructive sleep apnea, chronic snoring, or both, we want to help.


Who We Are

Sommetrics is focused on improving health and well-being by optimizing sleep quality. Using our proprietary aer+TM technology, our initial focus is on developing solutions for disorders related to the narrowing of the airway during sleep, such as obstructive sleep apnea (OSA), and in acute care medical procedures to safely support the patency of the upper airway requiring mild to moderate sedation. Our technology, which is utilized in our FDA-cleared product, will allow us to provide solutions to treat these disorders in a more effective and comfortable way than current products – serving a broader market. As we move forward, we will expand our products and services to help improve the quality of sleep for everyone.


The prevalence of obstructive sleep apnea and chronic snoring is impacting sleep quality worldwide. There is a need for an effective and easy-to-use solution to address both of these conditions.


of the adult population have obstructive sleep apnea.


of the adult population snore habitually, but do not have obstructive sleep apnea.


of obstructive sleep apnea cases are undiagnosed.


The Sommetrics Newsroom is where you’ll find up-to-date information about the company, including the latest press releases, as well as media coverage on sleep disorders and the impact poor quality sleep and snoring can have on your health and bed partner. In our newsroom, we also host aerBlog, where our experts cover a variety of topics, including sleep disorders, product updates, patient and physician resources, recent news, global trends in the sleep industry and more. Have a topic? Contact us to submit a suggestion to our team of experts.

Recent Press Releases

Sommetrics Adds Prominent Healthcare Leaders to Board of Directors and Advisory Board

SAN DIEGO, Calif. — November 30, 2017 — Sommetrics, a company providing products and services to improve sleep quality, today announced the addition of Raymond Huggenberger to its board of directors and Randall Whitfield to its advisory board. Earlier this month, the company announced its partnership with AvantSleep in Canada to distribute aerSleep Sommetrics’ sleep apnea therapy system. Sommetrics also recently engaged Key West Investments to help raise additional capital to support the development and commercialization of products and services to treat disorders of the upper airway, such as obstructive sleep apnea and snoring.

read more

Sommetrics Partners with AvantSleep to Market Novel Sleep Apnea Solution in Canada

SAN DIEGO, Calif. — November 7, 2017 — Sommetrics, a company providing products and services to improve sleep quality, today announced its partnership with AvantSleep to distribute the Sommetrics sleep apnea therapy system, aerSleep™, to Canadians diagnosed with obstructive sleep apnea (OSA). AvantSleep will distribute aerSleep™ in select Canadian markets, followed by a full Canadian launch in 2018.

read more

Recent aerBlog Posts

Ask the Expert: A New Approach to the Treatment of Obstructive Sleep Apnea by Jerrold Alan Kram, M.D., FCCP, FAASM

Q: Are there any new approaches to treating obstructive sleep apnea?

Obstructive sleep apnea (OSA) is an extremely common condition often estimated to be present in more than 10% of all adults. It is apnea, or difficulty breathing, that only occurs when we sleep. It is attributed to a combination of a patient’s anatomy and physiology. Anatomically, many patients with OSA have narrow or crowded pharyngeal areas, but the crucial change is in the physiology.

read more